Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Dec-22 5:29 PM View:  | Johnson Paula A Director | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 1,659 | -- | -- | (100%) 1.66K to 0 | |
| 27-Dec-22 8:44 PM View: | Puhy Dorothy E Director | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 14,590 | -- | -- | (100%) 14.59K to 0 | |
| 27-Dec-22 5:55 PM View: | Minogue Michael R Chairman, President, CEO Director | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 243,962 | -- | -- | (100%) 243.96K to 0 | |
| 27-Dec-22 5:19 PM View: | Rolle Myron L Director | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 1,721 | -- | -- | (100%) 1.72K to 0 | |
| 27-Dec-22 5:21 PM View: | Thomas Paul Director | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 6,357 | -- | -- | (100%) 6.36K to 0 | |
| 27-Dec-22 5:50 PM View: | Greenfield Andrew J VP, Chief Commercial Officer | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 23,484 | -- | -- | (100%) 23.48K to 0 | |
| 27-Dec-22 8:41 PM View: | Trapp Todd A Vice President, CFO | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 14,166 | -- | -- | (100%) 14.17K to 0 | |
| 27-Dec-22 8:37 PM View: | Plano Matthew T. VP, GLOBAL OPERATIONS | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 8,406 | -- | -- | (100%) 8.41K to 0 | |
| 27-Dec-22 5:55 PM View: | Minogue Michael R Chairman, President, CEO Director | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 166,670 | -- | -- | (41%) 410.63K to 243.96K | |
| 27-Dec-22 8:47 PM View: | Sutter Martin P Director | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 123,370 | -- | -- | (100%) 123.37K to 0 | |
| 27-Dec-22 5:46 PM View: | Began Marc A VP & General Counsel | Abiomed Inc. (NASD) | 22-Dec-22 | Disposition | 12,237 | -- | -- | (100%) 12.24K to 0 | |
| 20-Dec-22 4:05 PM View: | Greenfield Andrew J VP, Chief Commercial Officer | Abiomed Inc. (NASD) | 16-Dec-22 | Grant | 14 | -- | -- | < 1% 15.96K to 15.98K | |
| 20-Dec-22 4:02 PM View: | Minogue Michael R Chairman, President, CEO Director | Abiomed Inc. (NASD) | 16-Dec-22 | Grant | 1 | -- | -- | < 1% 380.05K to 380.05K | |
| 17-Nov-22 4:05 PM View: | Sutter Martin P Director | Abiomed Inc. (NASD) | 16-Nov-22 | Sale (Planned) | 2,000 | $374.73 | $749,450.00 | (2%) 121.37K to 119.37K | |
| 17-Nov-22 4:05 PM View: | Sutter Martin P Director | Abiomed Inc. (NASD) | 15-Nov-22 | Private Sale (Planned) | 2,000 | $374.50 | $749,008.00 | (2%) 123.37K to 121.37K | |
| 08-Nov-22 4:30 PM View: | Minogue Michael R Chairman, President, CEO Director | Abiomed Inc. (NASD) | 05-Nov-22 | Payment of Exercise | 5,164 | $373.99 | $1,931,280.00 | (< 1%) 536.67K to 531.51K | |
| 08-Nov-22 4:32 PM View: | Greenfield Andrew J VP, Chief Commercial Officer | Abiomed Inc. (NASD) | 05-Nov-22 | Payment of Exercise | 1,548 | $373.99 | $578,936.00 | (3%) 61.19K to 59.64K | |
| 08-Nov-22 4:28 PM View: | Trapp Todd A Vice President, CFO | Abiomed Inc. (NASD) | 05-Nov-22 | Payment of Exercise | 1,548 | $373.99 | $578,936.00 | (10%) 15.93K to 14.38K | |
| 08-Nov-22 4:34 PM View: | Began Marc A VP & General Counsel | Abiomed Inc. (NASD) | 05-Nov-22 | Payment of Exercise | 1,548 | $373.99 | $578,936.00 | (11%) 13.79K to 12.24K | |
| 08-Nov-22 4:34 PM View: | Began Marc A VP & General Counsel | Abiomed Inc. (NASD) | 04-Nov-22 | Private Sale (Planned) | 2,000 | $373.71 | $747,420.00 | (13%) 15.79K to 13.79K | |
| 03-Nov-22 4:50 PM View: | Thomas Paul Director | Abiomed Inc. (NASD) | 01-Nov-22 | Private Sale (Planned) | 1,000 | $379.38 | $379,380.00 | (14%) 7.36K to 6.36K | |
| 03-Nov-22 4:52 PM View: | Plano Matthew T. VP, GLOBAL OPERATIONS | Abiomed Inc. (NASD) | 01-Nov-22 | Planned Option Sale | 1,843 | $378.61 | $697,784.00 | (13%) 13.81K to 11.97K | |
| 03-Nov-22 4:48 PM View: | Trapp Todd A Vice President, CFO | Abiomed Inc. (NASD) | 01-Nov-22 | Private Sale (Planned) | 1,000 | $378.66 | $378,663.00 | (6%) 16.93K to 15.93K | |
| 03-Nov-22 4:52 PM View: | Plano Matthew T. VP, GLOBAL OPERATIONS | Abiomed Inc. (NASD) | 01-Nov-22 | Sale (Planned) | 1,701 | $378.61 | $644,021.00 | (14%) 11.97K to 10.27K | |
| 03-Nov-22 4:52 PM View: | Plano Matthew T. VP, GLOBAL OPERATIONS | Abiomed Inc. (NASD) | 01-Nov-22 | Option Exercise | 1,843 | $223.90 | $412,648.00 | 15% 11.97K to 13.81K | |
| 04-Oct-22 4:13 PM View: | Minogue Michael R Chairman, President, CEO Director | Abiomed Inc. (NASD) | 30-Sep-22 | Grant | 32 | -- | -- | < 1% 536.64K to 536.67K | |
| 04-Oct-22 4:16 PM View: | Greenfield Andrew J VP, Chief Commercial Officer | Abiomed Inc. (NASD) | 30-Sep-22 | Grant | 34 | -- | -- | < 1% 61.15K to 61.19K | |
| 30-Aug-22 4:34 PM View: | Began Marc A VP & General Counsel | Abiomed Inc. (NASD) | 29-Aug-22 | Sale (Planned) | 500 | $255.95 | $127,975.00 | (3%) 16.29K to 15.79K | |
| 17-Aug-22 5:09 PM View: | Sutter Martin P Director | Abiomed Inc. (NASD) | 17-Aug-22 | Market Sale (Planned) | 2,000 | $282.06 | $564,117.00 | (2%) 124.84K to 122.84K | (9%) |
| 17-Aug-22 5:09 PM View: | Sutter Martin P Director | Abiomed Inc. (NASD) | 16-Aug-22 | Market Sale (Planned) | 2,000 | $290.72 | $581,444.00 | (2%) 126.84K to 124.84K | (6%) |
| 12-Aug-22 4:15 PM View: | Sutter Martin P Director | Abiomed Inc. (NASD) | 11-Aug-22 | Payment of Exercise | 232 | $293.34 | $68,054.90 | (< 1%) 127.07K to 126.84K | |
| 12-Aug-22 4:12 PM View: | van Gorder Chris Director | Abiomed Inc. (NASD) | 11-Aug-22 | Payment of Exercise | 315 | $293.34 | $92,402.10 | (4%) 7.72K to 7.41K | |
| 12-Aug-22 4:20 PM View: | Plano Matthew T. VP, GLOBAL OPERATIONS | Abiomed Inc. (NASD) | 11-Aug-22 | Payment of Exercise | 749 | $293.34 | $219,712.00 | (6%) 12.72K to 11.97K | (5%) |
| 12-Aug-22 4:18 PM View: | Puhy Dorothy E Director | Abiomed Inc. (NASD) | 11-Aug-22 | Payment of Exercise | 263 | $293.34 | $77,148.40 | (2%) 15.23K to 14.97K | |
| 12-Aug-22 4:05 PM View: | Rose Eric A Md Director | Abiomed Inc. (NASD) | 11-Aug-22 | Payment of Exercise | 313 | $293.34 | $91,815.40 | (2%) 15.52K to 15.2K | |
| 12-Aug-22 4:07 PM View: | Rolle Myron L Director | Abiomed Inc. (NASD) | 11-Aug-22 | Payment of Exercise | 263 | $293.34 | $77,148.40 | (13%) 1.98K to 1.72K | |
| 12-Aug-22 4:10 PM View: | Thomas Paul Director | Abiomed Inc. (NASD) | 11-Aug-22 | Payment of Exercise | 232 | $293.34 | $68,054.90 | (3%) 7.59K to 7.36K | |
| 12-Aug-22 4:02 PM View: | Johnson Paula A Director | Abiomed Inc. (NASD) | 11-Aug-22 | Payment of Exercise | 263 | $293.34 | $77,148.40 | (14%) 1.92K to 1.66K | |
| 12-Aug-22 4:07 PM View: | Rolle Myron L Director | Abiomed Inc. (NASD) | 10-Aug-22 | Grant | 681 | -- | -- | 52% 1.3K to 1.98K | |
| 12-Aug-22 4:10 PM View: | Thomas Paul Director | Abiomed Inc. (NASD) | 10-Aug-22 | Grant | 681 | -- | -- | 10% 6.91K to 7.59K | |
| 12-Aug-22 4:12 PM View: | van Gorder Chris Director | Abiomed Inc. (NASD) | 10-Aug-22 | Grant | 681 | -- | -- | 10% 7.04K to 7.72K | |
| 12-Aug-22 4:05 PM View: | Rose Eric A Md Director | Abiomed Inc. (NASD) | 10-Aug-22 | Grant | 681 | -- | -- | 5% 14.84K to 15.52K | |
| 12-Aug-22 4:15 PM View: | Sutter Martin P Director | Abiomed Inc. (NASD) | 10-Aug-22 | Grant | 681 | -- | -- | < 1% 126.39K to 127.07K | |
| 12-Aug-22 4:03 PM View: | Rivet Jeannine M Director | Abiomed Inc. (NASD) | 10-Aug-22 | Grant | 681 | -- | -- | 7% 9.29K to 9.97K | |
| 12-Aug-22 4:02 PM View: | Johnson Paula A Director | Abiomed Inc. (NASD) | 10-Aug-22 | Grant | 681 | -- | -- | 55% 1.24K to 1.92K | |
| 12-Aug-22 4:18 PM View: | Puhy Dorothy E Director | Abiomed Inc. (NASD) | 10-Aug-22 | Grant | 681 | -- | -- | 5% 14.55K to 15.23K | |
| 05-Aug-22 4:03 PM View: | Trapp Todd A Vice President, CFO | Abiomed Inc. (NASD) | 03-Aug-22 | Market Sale (Planned) | 1,000 | $300.00 | $300,000.00 | (6%) 17.93K to 16.93K | (2%) |
| 31-May-22 5:27 PM View: | Greenfield Andrew J VP, Chief Commercial Officer | Abiomed Inc. (NASD) | 29-May-22 | Payment of Exercise | 1,320 | $266.34 | $351,569.00 | (2%) 62.47K to 61.15K | |
| 01-Jun-22 6:28 PM View: | Plano Matthew T. VP, GLOBAL OPERATIONS | Abiomed Inc. (NASD) | 29-May-22 | Payment of Exercise | 873 | $266.34 | $232,515.00 | (6%) 13.59K to 12.72K | |
| 31-May-22 5:29 PM View: | Trapp Todd A Vice President, CFO | Abiomed Inc. (NASD) | 29-May-22 | Grant | 2,600 | -- | -- | 15% 17.0K to 19.6K |
